1 dez. Metoclopramida, Tropisetron, Granisetron e Dexametasona. JUSTIFICATIVA E .. tratamento antiemético efetivo superam os dólares. com a diretriz foram prescrição de doses mais elevadas de dexametasona e . antiemético mais apropriado para cada agente antineoplásico isoladamente. Objetivo: evaluar el efecto profiláctico antiemético de la combinación dexametasona – metoclopramida en pacientes llevados a procedimientos.
|Published (Last):||19 July 2004|
|PDF File Size:||8.62 Mb|
|ePub File Size:||6.60 Mb|
|Price:||Free* [*Free Regsitration Required]|
Can J Anaesth ; Then, to characterize the differences between the procedures suggested by the guideline and those performed in clinical practice, and to evaluate the factors that contributed to adherence or non-adherence to protocols.
Based on dexametadona proposal, recommendations were developed to standardize the prophylactical use of antiemetics.
We excluded patients with insufficient information about the treatment, patients in concomitant chemotherapy and radiation therapy, and patients exclusively treated with targeted drug therapy e. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: Author information Article notes Copyright and License information Disclaimer. Cur Anaesth Dexametaslna Care ; The data used were historically recorded in databases, with no manipulation of personal information, nominal identification of patients or experiment with human beings, therefore no individual risk was involved.
American Society of Clinical Oncology clinical practice guideline update. Evidence-based management of postoperative nausea and vomiting: This study used the ASCO guideline 2 to assess adherence of oncologists to the recommended procedures. Guideline adherence rates generally also vary within each medical specialty.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Br J Anaesth ; Chemotherapy-induced nausea and vomiting. We do not intend to define the clinical practice in our country in absolute terms, but our results are consistent with literature data, and altogether demonstrate that much can be done to bring the clinical practice closer to evidence-based medicine.
The cost-effective management of postoperative nausea and vomiting.
There was a problem providing the content you requested
A simplified risk score for predicting postoperative nausea and vomiting: Proposal for classifying the acute emetogenicity of cancer chemotherapy.
American Society of Clinical Oncology top five list in oncology.
Author information Copyright and License information Disclaimer. Further studies are needed to define the duration of this effect of dexamethasone.
ANTIEMÉTICO – Definition and synonyms of antiemético in the Spanish dictionary
Antiemetic activity of the NK1 receptor antagonist GR in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Ina stratification of the emetogenic potential levels of chemotherapeutic agents, alone or in combination, was proposed.
For this purpose, cancer and palliative care organizations worldwide designed guidelines to indicate the most appropriate antiemetic regimen 267 for each antineoplastic agent, alone or in combination, and antiemeticp facilitate the management of cancer patients, based on the best scientific evidence.
Dado el bajo costo y falta de efectos adversos puede ser una de las primeras drogas a considerar para el tratamiento de la emesis posoperatoria en caso de no poder utilizarse el droperidol.
Support Center Support Center. Adherence to the antiemetic prophylaxis guidelines of the American Society of Clinical Oncology was low in the first cycle of antieemetico chemotherapy. Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. This was a retrospective and descriptive study, in which we collected data on the prescribed medications during the first cycle of chemotherapy, deexametasona patients who underwent chemotherapy between September and Februaryin the inpatient units and the outpatient chemotherapy sector of the Hospital Israelita Albert Einstein.
Patients aged 18 or older, who received cancer treatment for both hematologic and solid malignancies, were enrolled consecutively. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy. Treatment of postoperative nausea and vomiting: Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron.
Barriers to guidelines adherence. Risk factors for PONV were recorded. The antiemetic agents used for prophylaxis were evaluated as to the therapeutic class and dose. All the initial cycles of patients who underwent more than one line of chemotherapy during the period antiemteico included and analyzed, because the guideline used was published in Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Anesth Analg ; A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
The creation of incentive mechanisms, and checking adherence to protocols can be strategies for continuous improvement in health care. J Clin Anesth ; We thank the nurse Alessandra Cristina Mansur and the administrative technician Jacilene Marques de Morais, of the chemotherapy outpatient clinic of the Hospital Israelita Albert Einsteinfor their help in assessing the records of the patients treated at the institution.
Other variables considered significant in the univariate analysis were not determinant of guideline adherence or non-adherence after the multivariate analysis Table 3. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: Dexamethasone is useful as prophylaxis for postoperative nausea and vomiting PONV.